OpenText™ (NASDAQ: OTEX), (TSX: OTEX), today announced its roster of keynote and guest speakers for OpenText World 2024, the leading information management conference, set to take place in-person and ...
The European Commission is seeking feedback from industry players about Novo Holdings' $16.5 billion proposed acquisition of ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...
A summary of current health news details EU regulators probing Novo Nordisk's $16.5 billion Catalent takeover, Amgen's ...
This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...
European Union antitrust officials are asking rival pharmaceuticals firms for their input on Novo Holdings planned $16.5 ...
EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...
EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...
Zacks.com on MSN5d
JAZZ or CTLT: Which Is the Better Value Stock Right Now?Investors interested in Medical - Drugs stocks are likely familiar with Jazz Pharmaceuticals (JAZZ) and Catalent (CTLT). But which of these two stocks is more attractive to value investors? We'll need ...
The global biopharmaceutical contract manufacturing market is set for substantial growth, with a projected Compound Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback